Get started
Author

Susann Stephan-Falkenau

Observed names: S Stephan-Falkenau, S. Stephan-Falkenau, Stephan-Falkenau, Susann, Susanne Stephan-Falkenau
ORCID: 0000-0002-8487-5925
Observed ORCID: 0000-0002-8487-5925
OpenAlex ID: A5007037468
The frequency of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC): routine screening data for central Europe from a cohort study
2013 · Christian Boch, Jens Kollmeier, et al. · BMJ Open · 155
Efficacy of Immune Checkpoint Inhibitors Alone or in Combination With Chemotherapy in NSCLC Harboring ERBB2 Mutations
2021 · Felix C. Saalfeld, Carina Wenzel, et al. · Journal of Thoracic Oncology · 68
PDF
Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1–High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer
2023 · Philip Bischoff, Martin Reck, et al. · Journal of Thoracic Oncology · 60
PDF
Machine learning reveals a PD-L1–independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression context
2020 · Marcel Wiesweg, Fabian Mairinger, et al. · European Journal of Cancer · 56
Evaluation of the effectiveness of a nationwide precision medicine program for patients with advanced non-small cell lung cancer in Germany: a historical cohort analysis
2023 · Anika Kästner, Anna Kron, et al. · The Lancet Regional Health - Europe · 49
Reduced Folate Carrier and Folylpolyglutamate Synthetase, but not Thymidylate Synthase Predict Survival in Pemetrexed-Treated Patients Suffering from Malignant Pleural Mesothelioma
2013 · Fabian Mairinger, Claudia Vollbrecht, et al. · Journal of Thoracic Oncology · 24
Comparison of different semi-automated cfDNA extraction methods in combination with UMI-based targeted sequencing
2019 · Anna Streubel, Albrecht Stenzinger, et al. · Oncotarget · 19
PDF
Integrated Clinical, Molecular and Immunological Characterization of Pulmonary Sarcomatoid Carcinomas Reveals an Immune Escape Mechanism That May Influence Therapeutic Strategies
2023 · Susann Stephan-Falkenau, Anna Streubel, et al. · International Journal of Molecular Sciences · 16
PDF
Landscape of Genomic Alterations and PD-L1 Expression in Early-Stage Non-Small-Cell Lung Cancer (NSCLC)—A Single Center, Retrospective Observational Study
2022 · Susann Stephan-Falkenau, Anna Streubel, et al. · International Journal of Molecular Sciences · 12
PDF
Digital gene expression analysis of NSCLC-patients reveals strong immune pressure, resulting in an immune escape under immunotherapy
2022 · Michael Wessolly, Susann Stephan-Falkenau, et al. · BMC Cancer · 12
PDF
Chromogenic in situ hybridisation (CISH) is a powerful method to detect ALK-positive non-small cell lung carcinomas
2013 · F Wagner, A Streubel, et al. · Journal of Clinical Pathology · 10
Management of Locally Advanced or Metastatic Combined Hepatocellular Cholangiocarcinoma
2023 · Jemmy Zhao, Susann Stephan-Falkenau, et al. · Cancers · 9
PDF
A Novel Epitope Quality-Based Immune Escape Mechanism Reveals Patient’s Suitability for Immune Checkpoint Inhibition
2020 · Michael Wessolly, Susann Stephan-Falkenau, et al. · Cancer Management and Research · 8
PDF
A rare case of an EML4-ALK -rearranged lung adenocarcinoma missed by in situ-hybridisation but detected by RT-PCR
2014 · A Roth, A Streubel, et al. · Journal of Clinical Pathology · 7
Determinants of plasma calretinin in patients with malignant pleural mesothelioma
2020 · Martin Lehnert, Daniel G. Weber, et al. · BMC Research Notes · 4
PDF
Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions – a real-world retrospective analysis
2026 · Marie-Elisabeth Leßmann, Felix Carl Saalfeld, et al. · npj Precision Oncology · 1
PDF
Detection of clinically relevant gene fusions in plasma samples of lung cancer patients in routine molecular diagnostics.
2018 · Anna Streubel, Thomas Mairinger, et al. · Journal of Clinical Oncology · 1
Dyspnoe bei Jugendlichen – es ist nicht immer Asthma
2026 · Joanna Krist, Annette Günther, et al. · Zeitschrift für Pneumologie
Delayed Solitary Adrenal Metastasis in Malignant Pleural Mesothelioma with Long-Term Survival under Immunotherapy
2026 · Maximilian Franke, Halil Ibrahim Toy, et al. · Pneumologie
Metachrone Oligometastase der Nebenniere nach mehr als 5 Jahren Remission eines Malignen Pleuramesothelioms unter Immuntherapie
2026 · M Franke, N Stitterich, et al. · Pneumologie
Primärtherapien und deren Einfluss auf das mediane Gesamtüberleben bei 623 Pleuramesotheliom-Patienten im Zeitraum 1985-2020 – eine monozentrische, retrospektive Beobachtungsstudie
2024 · T Blum, J Kollmeier, et al. · Pneumologie
Characterization of fibrosis-associated pathways in human lung tissue samples in COVID-19 and fibrotic lung diseases
2023 · Cathrin Kodde, Torsten Blum, et al. · European Respiratory Journal
Eine pneumologische Rarität: primärer epitheloidzelliger Tumor (PECom) der Lunge
2023 · E Kruse, J Kollmeier, et al. · Pneumologie
Charakterisierung Fibrose-assoziierter Pathways mittels Transkriptom-Analysen in humanen Lungengeweben bei ARDS und chronischen Verlaufsformen von Covid-19 im Vergleich zu ARDS und chronischen ILD-Formen anderer Genese
2023 · C Kodde, T Blum, et al. · Pneumologie
Unklare Schwellung und Rötung nach einer Klavikulafraktur
2023 · U. Barth, D. Granowski, et al. · Die Chirurgie
PDF
Works count: 42
Citation count: 511
H-index: 10
I10-index: 11
Year
Topic
Type